Stakeholder analysis in pharmacogenomics and genomic medicine in Greece

Public Health Genomics

Volumn 17, Issue , 2014, Pages 280-286

  Mitropoulou, Christina ^a   Mai, Yuan ^b   Van Schaik, Ron H ^a   Vozikis, Athanassios ^c   Patrinos, George P ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF PATRAS   (Greece)

^c UNIVERSITY OF PIRAEUS   (Greece)

Author keywords

Genomic medicine strategic planning; Pharmacogenomics; Policymaking; Software; Stakeholders

Indexed keywords

ARTICLE; CLINICAL MEDICINE; COST EFFECTIVENESS ANALYSIS; GENETIC SCREENING; GENOME ANALYSIS; GREECE; HEALTH CARE COST; HUMAN; MEDICAL PRACTICE; PHARMACOGENOMICS; POLICY; PUBLIC HEALTH INSURANCE; REIMBURSEMENT; STRATEGIC PLANNING; ATTITUDE TO HEALTH; FACTUAL DATABASE; GENOMICS; LEGISLATION AND JURISPRUDENCE; MEDICAL RESEARCH; MEDICINE; PERSONALIZED MEDICINE; PHARMACOGENETICS; PROCEDURES;

ATTITUDE TO HEALTH; BIOMEDICAL RESEARCH; DATABASES, FACTUAL; GENOMICS; GREECE; HUMANS; INDIVIDUALIZED MEDICINE; MEDICINE; PHARMACOGENETICS; PUBLIC POLICY;

EID: 84909960398     PISSN: 16624246     EISSN: 16628063     Source Type: Journal    
DOI: 10.1159/000365896     Document Type: Article

References (15)

1. Guttmacher AE, McGuire AL, Ponder B, Stefánsson K: Personalized genomic information: preparing for the future of genetic medicine. Nat Rev Genet 2010; 11: 161-165.
2. Cooper DN, Chen JM, Ball EV, Howells K, Mort M, Phillips AD, Chuzhanova N, Krawczak M, Kehrer-Sawatzki H, Stenson PD: Genes, mutations, and human inherited disease at the dawn of the age of personalized genomics. Hum Mutat 2010; 31: 631-655.
3. Hietala M, Hakonen A, Aro AR, Niemelä P, Peltonen L, Aula P: Attitudes toward genetic testing among the general population and relatives of patients with a severe genetic disease: a survey from Finland. Am J Hum Genet 1995; 56: 1493-1500.
4. Balck F, Berth H, Meyer W: Attitudes toward genetic testing in a German population. Genet Test Mol Biomarkers 2009; 13: 743-750.
5. Makeeva OA, Markova VV, Roses AD, Puzyrev VP: An epidemiologic-based survey of public attitudes towards predictive genetic testing in Russia. Pers Med 2010; 7: 291-300.
6. Mai Y, Koromila K, Sagia A, Cooper DN, Vlachopoulos G, Lagoumintzis G, Kollia P, Poulas K, Stathakopoulos V, Patrinos GP: A critical view of the general public's awareness and physicians' opinion of the trends and potential pitfalls of genetic testing in Greece. Pers Med 2011; 8: 551-561.
7. Mai Y, Mitropoulou C, Papadopoulou XE, Vozikis A, Cooper DN, van Schaik RH, Patrinos GP: Critical appraisal of the views of healthcare professionals with respect to pharmacogenomics and personalized medicine in Greece. Pers Med 2014; 11: 15-26.
8. Sagia A, Cooper DN, Poulas K, Stathakopoulos V, Patrinos GP: A critical appraisal of the private genetic and pharmacogenomic testing environment in Greece. Pers Med 2011; 8: 413-420.
9. Reich RM: Applied political analysis for health policy reform. Curr Iss Public Health 1996; 2: 186-191.
10. Reich MR, Cooper DM: PolicyMaker: Computer-Assisted Political Analysis. Software and Manual. Newton Centre, PoliMap, 1996.
11. Glassman A, Reich MR, Laserson K, Rojas F: Political analysis of health reform in the Dominican Republic. Health Policy Plan 1999; 14: 115-126.
12. Mintzberg H: The Rise and Fall of Strategic Planning. New York, Free Press, 1994.
13. European Commission: The Second Economic Adjustment Programme for Greece: Third Review. European Economy, Occasional Papers 159, European Commission, Directorate-General for Economic and Financial Affairs. Brussels, 2013.
14. Patrinos GP, Baker DJ, Al-Mulla F, Vasiliou V, Cooper DN: Genetic tests obtainable through pharmacies: the good, the bad, and the ugly. Hum Genomics 2013; 7: 17.
15. Kampourakis K, Vayena E, Mitropoulou C, van Schaik RH, Cooper DN, Borg J, Patrinos GP: 2014 Key challenges for next-generation pharmacogenomics: Science & Society series on Science and Drugs. EMBO Rep 2014; 15: 472-476.